FDA Approved: SYEDA — Supplemental Application (Xiromed, LLC.)

View source ↗

Summary

FDA approved a supplemental application for SYEDA, a drospirenone and ethinyl estradiol combination oral contraceptive, manufactured by Xiromed, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• SYEDA (DROSPIRENONE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for SYEDA (DROSPIRENONE AND ETHINYL ESTRADIOL)